PPBT
Purple Biotech Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.75
−11.62%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-199.6%
Return on equity
-172.9%
Return on assets
-228.6%
Return on invested capital
0.00x
Asset turnover
-$7.8M
Cash from operations
$3.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026